Lipodystrophies: Genetic and acquired body fat disorders

Chemical Compounds

• Fat 73%
• Disorder 63%
• Mutation 62%
• Metabolic 60%
• Antilipemic Agent 57%
• Antiretroviral 52%
• Antidiabetic Agent 45%
• Cosmetic 37%
• Insulin Derivative 37%
• Resistance 23%
• Pressure 21%
• Drug 19%

Medicine & Life Sciences

• Lipodystrophy 100%
• Adipose Tissue 61%
• Familial Partial Lipodystrophy 42%
• Congenital Generalized Lipodystrophy 40%
• Lipodystrophy, Partial, Acquired 15%
• Panniculitis 11%
• Recessive Genes 11%
• Hypertriglyceridemia 9%
• Highly Active Antiretroviral Therapy 9%
• Mutation 9%
• Plastic Surgery 9%
• Protease Inhibitors 8%
• Hypoglycemic Agents 7%
• Inborn Genetic Diseases 7%
• Insulin Resistance 6%
• Molecular Biology 6%
• Diabetes Mellitus 6%
• PubMed 6%
• Fats 6%
• Vaccines 6%
• HIV 5%
• Diet 5%
• Lipids 5%
• Exercise 5%
• Pressure 5%
• Injections 4%
• Liver 4%
• Pharmaceutical Preparations 3%
• Therapeutics 1%